Cargando…
Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment
Idiopathic pulmonary fibrosis (IPF) is the most common progressive interstitial disease of unknown etiology. The course of the disease cannot be predicted with certainty. It is crucial to regularly monitor the disease using multiple assessments to evaluate its progression. Currently, there is no con...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540722/ https://www.ncbi.nlm.nih.gov/pubmed/37712374 http://dx.doi.org/10.36141/svdld.v40i3.14048 |